Management of chronic daily headache in children

Expert Review of Neurotherapeutics

Volumn 10, Issue 9, 2010, Pages 1479-1486

  Mack, Kenneth J ^a  

^a MAYO CLINIC   (United States)

Author keywords

chronic daily headache; chronic migraine; migraine; pediatric

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; FLUNARIZINE; FLUOXETINE; GABAPENTIN; NORTRIPTYLINE; PROPANOL; PROTRIPTYLINE; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

ANXIETY DISORDER; ASTHMA; CHILDHOOD DISEASE; CHRONIC DAILY HEADACHE; COMORBIDITY; CONSTIPATION; DECREASED APPETITE; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FATIGUE; HUMAN; IRRITABILITY; LIVER TOXICITY; MEDICAL DECISION MAKING; MOOD CHANGE; MOOD DISORDER; NIGHTMARE; PAIN; PANCREAS DISEASE; REVIEW; SIDE EFFECT; SOMNOLENCE; SWELLING; SYMPTOM; TERATOGENICITY; THOUGHT DISORDER; WEIGHT GAIN;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BOTULINUM TOXINS; CHILD; HEADACHE DISORDERS; HUMANS;

EID: 77956491808     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.124     Document Type: Review

References (54)

1. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ 309, 765-769 (1994).
2. Aromaa M, Sillanpaa ML, Rautava P. Childhood headache at school entry: a controlled clinical study. Neurology 50, 1729-1736 (1998)
3. International classifcation of headache disorders (ICHD-II). Cephalalgia 24(Suppl. 1), 23-136 (2004).
4. Wang SJ, Fuh JL, Lu SR, Juang KD. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 66, 193-197 (2006).
5. Kavuk I, Yavuz A, Cetindere U, Agelink MW, Diener HC. Epidemiology of chronic daily headache. Eur. J. Med. Res. 8, 236-240 (2003).
6. Gladstein J, Holden EW Chronic daily headache in children and adolescents: a 2-year prospective study. Headache 36, 349-351 (1996).
7. Mack KJ. What incites new daily persistent headache in children? Pediatr. Neurol. 31, 122-125 (2004).
8. Gladstein J, Holden EW, Peralta L, Raven M. Diagnoses and symptom patterns in children presenting to a pediatric headache clinic. Headache 33, 497-500 (1993).
9. Couch JR. The tension headache component of chronic daily headache. Curr. Pain Headache Rep. 8, 479-483 (2004).
10. Howard L, Wessely S, Leese M et al. Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache. J. Neurol. Neurosurg. Psychiatry 76, 1558-1564 (2005)
11. Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 44, 1353-1354 (1994).
12. Schwedt TJ, Guo Y, Rothner AD. 'Benign' imaging abnormalities in children and adolescents with headache. Headache 46, 387-398 (2006).
13. Arnold M, Cumurciuc R, Stapf C, Favrole P, Berthet K, Bousser MG. Pain as the only symptom of cervical artery dissection. J. Neurol. Neurosurg. Psychiatry 77, 1021-1024 (2006). (Pubitemid 44338521)
14. Evans RW. Diagnostic testing for chronic daily headache. Curr. Pain Headache Rep. 11, 47-52 (2007).
15. Maizels M, Burchette R. Somatic symptoms in headache patients: the infuence of headache diagnosis, frequency, and comorbidity. Headache 44, 983-993 (2004).
16. Rains JC. Chronic headache and potentially modifable risk factors: screening and behavioral management of sleep disorders. Headache 48(1), 32-39 (2008).
17. Johnson JN, Mack KJ, Kuntz NL, Brands CK, Porter CJ, Fischer PR. Postural orthostatic tachycardia syndrome-a clinical review. Pediatr. Neurol. 42(2), 77-85 (2010).
18. Wang SJ, Juang KD, Fuh JL, Lu SR. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 68 (18), 1468-1473 (2007).
19. Mack KJ, Terrell KW Chronic daily headache of childhood is a complex of multiple symptoms. American Headache Society. Headache 43, 572 (2003).
20. Lewis D, Ashwal S, Hershey A et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63, 2215-2224 (2004). (Pubitemid 40024327)
21. Diener HC, Schorn CF, Bingel U, Dodick DW The importance of placebo in headache research. Cephalalgia 28(10), 1003-1011 (2008).
22. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71(8), 559-566 (2008).
23. Descombes S, Brefel-Courbon C, Thalamas C et al. Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache 41(2), 178-182 (2001).
24. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 40, 539-549 (2000).
25. Gherpelli JL, Esposito SB. A prospective randomized double blind placebo controlled crossover study of fuoxetine effcacy in the prophylaxis of chronic daily headache in children and adolescents. Arq. Neuropsiquiatr. 63(3A), 559-563 (2005).
26. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201 (TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27(7), 814-823 (2007).
27. Silberstein S, Lipton R, Dodick D et al Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other effcacy measures. Headache 49(8), 1153-1162 (2009).
28. Lewis D, Winner P, Saper J et al. Randomized, double-blind, placebocontrolled study to evaluate the effcacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 123(3), 924-934 (2009).
29. Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache 41(3), 271-278 (2001). (Pubitemid 32242612)
30. Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. J. Headache Pain 9(1), 37-41 (2008).
31. Apostol G, Lewis DW, Laforet GA et al Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache 49(1), 45-53 (2009).
32. Ashraf MR, Shabanian R, Zamani GR, Mahfelati F. Sodium valproate versus propranolol in paediatric migraine prophylaxis. Eur. J. Paediatr. Neurol. 9(5), 333-338 (2005).
33. Spira PJ, Beran RG; Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 61(12), 1753-1759 (2003). (Pubitemid 38020824)
34. Pascual J, Rivas MT, Leira R. Testing the combination b-blocker plus topiramate in refractory migraine. Acta Neurol. Scand. 115(2), 81-83 (2007).
35. Reveiz-Herault L, Cardona AF, Ospina EG, Carrillo P. Effectiveness of funarizine in the prophylaxis of migraine: a meta-analytical review of the literature. Rev. Neurol. 36(10), 907-912 (2003).
36. Naumann M, So Y, Argoff CE et al. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70, 1707-1714 (2008). (Pubitemid 351644139)
37. Mathew NT, Jaffri SF. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache 49(10), 1466-1478 (2009).
38. Blumenfeld AM, Schim JD, Chippendale TJ. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache 48(2), 210-220 (2008).
39. Aurora SK, Dodick DW, Turkel CC et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT-1 trial. Cephalalgia 30, 793-803 (2010).
40. Diener HC, Dodick DW, Aurora SK et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30, 804-814 (2010).
41. Chan V W, McCabe EJ, MacGregor DL. Botox treatment for migraine and chronic daily headache in adolescents. J. Neurosci. Nurs. 41(5), 235-243 (2009).
42. Ahmed K, Oas KH, Mack KJ, Garza I. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache. Pediatr. Neurol. (2010) (In press).
43. Marmura MJ, Silberstein SD, Gupta M. Hemicrania continua: who responds to indomethacin? Cephalalgia 29(3), 300-307 (2009).
44. Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology 71, 1821-1828 (2008).
45. Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr. Emerg Care 24(5), 321-330 (2008).
46. Raskin NH. Repetitive intravenous ergotamine therapy for the treatment of intractable migraine. Neurology 36, 995-997 (1986).
47. Pringsheim T, Howse D. In-patient treatment of chronic daily headache using di hydro ergotamine: a long-term follow-up study. Can. J. Neurol. Sci. 25(2), 146-150 (1998).
48. Schwartz TH, Karpitskiy V V, Sohn RS. Intravenous valproate sodium in the treatment of daily headache. Headache 42, 519-522 (2002).
49. Prakash S, Shah ND. Post-infectious new daily persistent headache may respond to intravenous methylprednisolone. J. Headache Pain 11(1), 59-66 (2010).
50. Trautmann E, Lackschewitz H, Kröner-Herwig B. Psychological treatment of recurrent headache in children and adolescents-a meta-analysis. Cephalalgia 26(12), 1411-1426 (2006).
51. Coeytaux RR, Kaufman JS, Kaptchuk TJ et al. A randomized, controlled trial of acupuncture for chronic daily headache. Headache 45(9), 1113-1123 (2005).
52. Mauskop A. Alternative therapies in headache. Is there a role? Med. Clin. North Am. 85, 1077-1084 (2001).
53. Silberstein SD. Comprehensive management of headache and depression. Cephalalgia 18(Suppl. 21), 50-55 (1998).
54. Wang SJ, Fuh JL, Lu SR. Chronic daily headache in adolescents: an 8-year follow-up study. Neurology 73(6), 416-422 (2009).